Abstract
Routine investigation for recurrent pregnancy loss includes measurement of antiphospholipid antibodies. The lupus anticoagulant has long been associated with increased risks for thrombosis and adverse obstetric outcomes. But there are some disadvantages with lupus anticoagulant (LAC) tests which includes varied sensitivity of different clot based assays. ISTH recommends only 2 assays (preferably DRVVT and APTT-LA) for the identification of lupus anticoagulant but there are some studies which don’t support this contention. Our study analyzed 526 samples from high risk pregnancy cases for APLA by all four LAC tests from tertiary centre of northern India. Among all the cases studies 65 cases were positive for lupus anticoagulant 25 of this became negative after 12 weeks. Among the 40 repeated positive assays, dRVVT could able to diagnose 36 cases followed by APTT-LA which could able to diagnose 28 cases, while KCT could able to diagnose 23 cases and dPT could able to diagnose only 14 cases. There were 12 cases in whom all lupus assays were positive. Our study thus concluded that DRVVT was the most sensitive followed by APPT-LA, KCT, dPT. The combination of dRVVT with APTT-LA or KCT appeared to be superior to other combinations. No individual test per se is 100% sensitive for the diagnosis of APLA in high risk pregnancy cases. Further results confirmed that repeated LAC result is required even in a high-risk setting. Positive LAC assay in majority were not associated with exclusively recurrent pregnancy loss but were associated with sporadic stillbirth and thrombosis.
Similar content being viewed by others
References
Lubbe WF, Liggins GC (1985) Lupus anticoagulant and pregnancy. Am J Obstet Gynecol 153:322–327
Branch DW, Scott JR, Kochenour NK, Hershgold E (1985) Obstetric complications associated with the lupus anticoagulant. N Engl J Med 313:1322–1326
Pengo V, Tripodi A, Reber G et al (2009) Update of the guidelines for lupus anticoagulant detection. Subcommittee on lupus anticoagulant/antiphospholipid antibody of the scientific and standardisation committee of the International Society on Thrombosis and Haemostasis. J Thromb Haemost 7:1737–1740
Wilson WA, Gharavi AE, Koike T, Lockshin MD, Branch DW, Piette JC et al (1999) International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop. Arthr Rheum 42:1309–1311
Galli M, Reber G, de Moerloose P, de Groot PG (2008) Invitation to a debate on the serological criteria that define the antiphospholipid syndrome. J Thromb Haemost 6:399–401
Galli M, Finazzi G, Bevers EM, Barbui T (1995) Kaolin clotting time and dilute Russell’s viper venom time distinguish between prothrombin-dependent and beta 2-glycoprotein I-dependent antiphospholipid antibodies. Blood 86:617–623
Keeling D, Mackie I, Moore GW, Greer IA, Greaves M (2012) British committee for standards in haematology. Br J Haematol 157:47–58
Pengo V, Biasiolo A, Gresele P et al (2007) Participating centres of Italian Federation of Thrombosis Centres (FCSA). Survey of lupus anticoagulant diagnosis by central evaluation of positive plasma samples. J Thromb Haemost 5:925–930
Jennings I, Mackie I, Arnout J, Preston FE (2004) UK national external quality assessment scheme for blood coagulation. Lupus anticoagulant testing using plasma spiked with monoclonal antibodies: performance in the UK NEQAS proficiency testing programme. J Thromb Haemost 2:2178–2184
Arnout J, Vanrusselt M, Huybrechts E, Vermylen J (1994) Optimization of the dilute prothrombin time for the detection of the lupus anticoagulant by use of a recombinant tissue thromboplastin. Br J Haematol 87:94–99
Bowie EJ, Thompson JH Jr, Pascuzzi CA, Owen CA Jr (1963) Thrombosis in systemic lupus erythematosus despite circulating anticoagulants. J Lab Clin Med 62:416–430
Mueh JR, Herbst KD, Rapaport SI (1980) Thrombosis in patients with the lupus anticoagulant. Ann Intern Med 92:156–159
Clarke CA, Davidovits J, Spitzer KA, Laskin CA (2013) Lupus anticoagulant: results from 2257 patient attending a high risk pregnancy clinic. Blood 18(122):341–347
Vora S, Shetty S, Salvi V, Satoskar P, Ghosh K (2008) Thrombophilia and unexplained pregnancy loss in Indian patients. Natl Med J India 21:116–119
Swadzba J, Iwaniec T, Pulka M, De Laat B, De Groot PG, Musial J (2011) Lupus anticoagulant: performance of the tests as recommended by the latest ISTH guidelines. J Thromb Haemost 9:1776–1783
Helgadóttir LB, Turowski G, Skjeldestad FE, Jacobsen AF, Sandset PM, Roald B et al (2013) Classification of stillbirths and risk factors by cause of death—a case–control study. Acta Obstet Gynecol Scand 92:325–333
Duley L (2009) The global impact of pre-eclampsia and eclampsia. Semin Perinatol 33:130–137
Miyakis S, Lockshin MD, Atsumi D, Branch DW, Brey RL, Cervera R et al (2006) International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 4:295–306
Alijotas-Reig J, Ferrer-Oliveras R, Ruffatti A, Tincani A, Lefkou E, Bertero MT et al (2015) The European Registry on Obstetric Antiphospholipid Syndrome (EUROAPS): a survey of 247 consecutive cases. Autoimmun Rev 14:387–395
Bouvier S, Cochery-Nouvellon E, Lavigne-Lissalde G, Mercier E, Marchetti T, Balducchi JP et al (2014) Comparative incidence of pregnancy outcomes in treated obstetric antiphospholipid syndrome: the NOH-APS observational study. Blood 16(123):404–413
Fischer-Betz R, Specker C, Brinks R, Schneider M (2012) Pregnancy outcome in patients with antiphospholipid syndrome after cerebral ischaemic events: an observational study. Lupus 21:1183–1189
Barbour LA (2001) ACOG committee on practice bulletins-obstetrics. Int J Gynaecol Obstet 75(2):203–212
Branch DW, Silver RM, Porter TF (2010) Obstetric in antiphospholipid syndrome: current uncertainties should guide our way. Lupus 19:446–452
Skrzypczak J, Rajewski M, Wirstlein P, Goździewicz T, Zimmer M, Wołczyński S et al (2011) Frequency of antiphospholipid syndrome in women with pregnancy loss in multicenter study in Poland. Ginekol Pol 82:749–754
Martinuzzo ME, Cerrato GS, Varela ML, Adamczuk YP, Forastiero RR (2012) New guidelines for lupus anticoagulant: sensitivity and specificity of cut-off values calculated with plasmas from healthy controls in mixing and confirmatory tests. Int J Lab Hematol 34:208–213
Exner T, Rickard KA, Kronenberg H (1978) A sensitive test demonstrating lupus anticoagulant and its behavioural patterns. Br J Haematol 40:143–151
Pengo V, Biasiolo A, Rampazzo P, Brocco T (1999) dRVVT is more sensitive than KCT or TTI for detecting lupus anticoagulant activity of anti-beta2-glycoprotein I autoantibodies. Thromb Haemost 81:256–258
Urbanus RT, de Groot PG (2011) Antiphospholipid antibodies—we are not quite there yet. Blood Rev 25:97–106
Acknowledgements
We acknowledge the support of our patients and technical staff, as with their support the study had been feasible.
Funding
This study was funded by Haematology Research Society (Grant Number 01) and we are very grateful to them for helping us in research process.
Author information
Authors and Affiliations
Contributions
RS, HPT, AA and ST were involved in conceptualization, designing, writing and critical review of the manuscript and were responsible for overall supervision. PM, AA, DC, PT and VS were involved in literature search, writing and manuscript editing. ST is the overall guarantor of the article.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interests.
Ethical Approval
The present study is in compliance with ethical standards.
Informed Consent
Informed consent was obtained from all individual participants included in the study.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Ahuja, A., Tyagi, S., Pati, H.P. et al. Utility of Lupus Anticoagulant Assays (APTT-LA, KCT, DPT and DRVVT) in Detection of Antiphospholipid Syndrome (APS) in High Risk Pregnancy Cases. Indian J Hematol Blood Transfus 35, 478–484 (2019). https://doi.org/10.1007/s12288-018-01072-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12288-018-01072-8